Physician profile
Eric K Botts
NPI 1457301368
$1,250.40
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $475 · 2021: $109.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $593.50 | 2019-2020 | |
| Allergan, INC. | $384.53 | 2019-2021 | |
| Maculogix, INC. | $102.53 | 2019 | |
| Glaukos Corporation | $57.83 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $52.13 | 2019 | |
| Shire North American Group INC | $36.63 | 2019 | |
| Optos, INC. | $11.72 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $11.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Botts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.